Evidence map›Paper›PMID 26322848›Full record

ArticleMolecular medicine (Cambridge, Mass.)2015

Association between

Ramune Sepetiene, Vaiva Patamsyte, Giedrius Zukovas, Giedre Jariene, Zita Stanioniene, Rimantas Benetis, Abdonas Tamosiunas, Vaiva Lesauskaite

Open access · goldAbstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Aetiology and management of hereditary aortopathy.Nature reviews. Cardiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ramune SepetieneInstitute of Cardiology of the Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Vaiva PatamsyteInstitute of Cardiology of the Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Giedrius ZukovasDepartment of Cardiac, Thoracic and Vascular Surgery, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Giedre JarieneInstitute of Cardiology of the Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Zita StanionieneInstitute of Cardiology of the Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Rimantas BenetisInstitute of Cardiology of the Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Abdonas TamosiunasInstitute of Cardiology of the Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Vaiva LesauskaiteInstitute of Cardiology of the Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Lithuanian University of Health Sciences · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transforming growth factor (TGF)-β1 is a cytokine that participates in a broad range of cellular regulatory processes and is associated with various diseases including aortic aneurysm. Increased TGF-β1 levels are linked to Marfan syndrome (MFS) caused by

Identifiers

PMID26322848
PMCPMC4749488
OpenAlexW2414886317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.